241 related articles for article (PubMed ID: 12594839)
1. Experimental African trypanosomiasis: IFN-gamma mediates early mortality.
Shi M; Pan W; Tabel H
Eur J Immunol; 2003 Jan; 33(1):108-18. PubMed ID: 12594839
[TBL] [Abstract][Full Text] [Related]
2. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
Uzonna JE; Kaushik RS; Gordon JR; Tabel H
J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells.
Shi M; Wei G; Pan W; Tabel H
J Leukoc Biol; 2004 Aug; 76(2):399-405. PubMed ID: 15136584
[TBL] [Abstract][Full Text] [Related]
4. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice.
Kaushik RS; Uzonna JE; Zhang Y; Gordon JR; Tabel H
Cytokine; 2000 Jul; 12(7):1024-34. PubMed ID: 10880248
[TBL] [Abstract][Full Text] [Related]
5. Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense.
Shi M; Wei G; Pan W; Tabel H
Infect Immun; 2005 Dec; 73(12):8393-6. PubMed ID: 16299337
[TBL] [Abstract][Full Text] [Related]
6. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice.
Kaushik RS; Uzonna JE; Gordon JR; Tabel H
Exp Parasitol; 1999 Jun; 92(2):131-43. PubMed ID: 10366538
[TBL] [Abstract][Full Text] [Related]
7. Altered proinflammatory cytokine production and enhanced resistance to Trypanosoma congolense infection in lymphotoxin beta-deficient mice.
Okwor I; Muleme H; Jia P; Uzonna JE
J Infect Dis; 2009 Aug; 200(3):361-9. PubMed ID: 19563258
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12p70 deficiency increases survival and diminishes pathology in Trypanosoma congolense infection.
Barkhuizen M; Magez S; Ryffel B; Brombacher F
J Infect Dis; 2008 Nov; 198(9):1284-91. PubMed ID: 18816189
[TBL] [Abstract][Full Text] [Related]
9. Resistance to the African trypanosomes is IFN-gamma dependent.
Hertz CJ; Filutowicz H; Mansfield JM
J Immunol; 1998 Dec; 161(12):6775-83. PubMed ID: 9862708
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection.
Haas KM; Taylor KA; MacHugh ND; Kreeger JM; Estes DM
J Leukoc Biol; 2001 Dec; 70(6):931-40. PubMed ID: 11739556
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
Hertz CJ; Mansfield JM
Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis.
Barkhuizen M; Magez S; Atkinson RA; Brombacher F
J Infect Dis; 2007 Oct; 196(8):1253-60. PubMed ID: 17955445
[TBL] [Abstract][Full Text] [Related]
13. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4.
Bakhiet M; Jansson L; Büscher P; Holmdahl R; Kristensson K; Olsson T
J Immunol; 1996 Oct; 157(8):3518-26. PubMed ID: 8871651
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during trypanosoma congolense Tc13 Infections.
Magez S; Radwanska M; Drennan M; Fick L; Baral TN; Brombacher F; De Baetselier P
J Infect Dis; 2006 Jun; 193(11):1575-83. PubMed ID: 16652287
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis.
Namangala B; Noël W; De Baetselier P; Brys L; Beschin A
J Infect Dis; 2001 Jun; 183(12):1794-800. PubMed ID: 11372033
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of self-cure from Trypanosoma congolense infection in mice.
Pinder M; Chassin P; Fumoux F
J Immunol; 1986 Feb; 136(4):1427-34. PubMed ID: 3484768
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma congolense infections: MHC class II-restricted immune responses mediate either protection or disease, depending on IL-10 function.
Shi MQ; Wei GJ; Tabel H
Parasite Immunol; 2007 Feb; 29(2):107-11. PubMed ID: 17241399
[TBL] [Abstract][Full Text] [Related]
18. Experimental African trypanosomiasis: a subset of pathogenic, IFN-gamma-producing, MHC class II-restricted CD4+ T cells mediates early mortality in highly susceptible mice.
Shi M; Wei G; Pan W; Tabel H
J Immunol; 2006 Feb; 176(3):1724-32. PubMed ID: 16424202
[TBL] [Abstract][Full Text] [Related]
19. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
[TBL] [Abstract][Full Text] [Related]
20. Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance.
Uzonna JE; Kaushik RS; Gordon JR; Tabel H
Parasite Immunol; 1999 Feb; 21(2):57-71. PubMed ID: 10101716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
